Novo Nordisk will spend £115m over a 10-year period on a new research facility in Oxford.
The Danish company’s executive vice-president and chief science officer, Mads Thomsen, described the UK’s decision to leave the European Union
Novo Nordisk will spend £115m over a 10-year period on a new research facility in Oxford.
The Danish company’s executive vice-president and chief science officer, Mads Thomsen, described the UK’s decision to leave the European Union
Our mission is to support you in finding and assessing investment and development opportunities faster.
Help us do just that by taking part in an exclusive product testing session.
Sign up nowKind regards,
The EG team